» Articles » PMID: 21843370

Peripheral Anti-inflammatory Effects Explain the Ginsenosides Paradox Between Poor Brain Distribution and Anti-depression Efficacy

Overview
Publisher Biomed Central
Date 2011 Aug 17
PMID 21843370
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The effectiveness of ginseng in preventing and treating various central nervous system (CNS) diseases has been widely confirmed. However, ginsenosides, the principal components of ginseng, are characterized by poor accessibility to the brain, and this pharmacokinetic-pharmacological paradox remains poorly explained. Anti-inflammatory approaches are becoming promising therapeutic strategies for depression and other CNS diseases; however, previous studies have focused largely on anti-inflammatory therapies directed at the central nervous system. It is thus of interest to determine whether ginsenosides, characterized by poor brain distribution, are also effective in treating lipopolysaccharide- (LPS) induced depression-like behavior and neuroinflammation.

Methods: In an LPS-induced depression-like behavior model, the antidepressant effects of ginseng total saponins (GTS) were assessed using a forced swimming test, a tail suspension test, and a sucrose preference test. The anti-inflammatory efficacies of GTS in brain, plasma, and LPS-challenged RAW264.7 cells were validated using ELISA and quantitative real-time PCR. Moreover, indoleamine 2,3-dioxygenase (IDO) activity in the periphery and brain were also determined by measuring levels of kynurenine/tryptophan.

Results: GTS significantly attenuated LPS-induced depression-like behavior. Moreover, LPS-induced increases in 5-HT and tryptophane turnover in the brain were significantly reduced by GTS. IDO activities in brain and periphery were also suppressed after pretreatment with GTS. Furthermore, GTS-associated recovery from LPS-induced depression-like behavior was paralleled with reduced mRNA levels for IL-1β, IL-6, TNF-α, and IDO in hippocampus. Poor brain distribution of ginsenosides was confirmed in LPS-challenged mice. GTS treatment significantly decreased production of various proinflammatory cytokines in both LPS-challenged mice and RAW264.7 cells.

Conclusion: This study suggests that the anti-depression efficacy of GTS may be largely attributable to its peripheral anti-inflammatory activity. Our study also strengthens an important notion that peripheral anti-inflammation strategies may be useful in the therapy of inflammation-related depression and possibly other CNS diseases.

Citing Articles

The impact and mechanisms of YL-IPA08, a potent ligand for the translocator protein (18 kDa) on protection against LPS-induced depression and cognitive dysfunction in rodents.

Cui L, Duan J, Yan J, Wang J, Ren P, Zhang L Metab Brain Dis. 2025; 40(3):137.

PMID: 40047959 DOI: 10.1007/s11011-025-01565-2.


Efficacy of ginsenoside Rg1 on rodent models of depression: A systematic review and meta-analysis.

Wang Y, Wang X, Lei L, Zhang Y Psychopharmacology (Berl). 2024; .

PMID: 39039242 DOI: 10.1007/s00213-024-06649-y.


Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19.

Zhao F, Zhang K, Chen H, Zhang T, Zhao J, Lv Q Inflammopharmacology. 2023; 32(1):229-247.

PMID: 38012459 PMC: 10907431. DOI: 10.1007/s10787-023-01380-0.


Altered Tryptophan-Kynurenine Pathway in Delirium: A Review of the Current Literature.

Phing A, Makpol S, Nasaruddin M, Wan Zaidi W, Ahmad N, Embong H Int J Mol Sci. 2023; 24(6).

PMID: 36982655 PMC: 10056900. DOI: 10.3390/ijms24065580.


History and main research of psychoneuroimmunology in China.

Wang W, Lin W, Chen G, You Z Brain Behav Immun Health. 2022; 26:100562.

PMID: 36478914 PMC: 9719853. DOI: 10.1016/j.bbih.2022.100562.


References
1.
Hao H, Cui N, Wang G, Xiang B, Liang Y, Xu X . Global detection and identification of nontarget components from herbal preparations by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a strategy. Anal Chem. 2008; 80(21):8187-94. DOI: 10.1021/ac801356s. View

2.
Sanchez M, Alagbe O, Felger J, Zhang J, Graff A, Grand A . Activated p38 MAPK is associated with decreased CSF 5-HIAA and increased maternal rejection during infancy in rhesus monkeys. Mol Psychiatry. 2007; 12(10):895-7. DOI: 10.1038/sj.mp.4002025. View

3.
Krishnan V, Nestler E . The molecular neurobiology of depression. Nature. 2008; 455(7215):894-902. PMC: 2721780. DOI: 10.1038/nature07455. View

4.
Kaper T, Looger L, Takanaga H, Platten M, Steinman L, Frommer W . Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. PLoS Biol. 2007; 5(10):e257. PMC: 1988858. DOI: 10.1371/journal.pbio.0050257. View

5.
Hui E, Boado R, Pardridge W . Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier. Mol Pharm. 2009; 6(5):1536-43. DOI: 10.1021/mp900103n. View